The regulation of blood coagulation in liver transplant recipients with end-stage cirrhosis

蒋忠,马正良,靳艳卿,周路阳
2008-01-01
Abstract:Objective To investigate the appropriate modulation of coagulation function during orthotropic liver transplantation in patients with end-stage hepatocirrhosis.Methods Fifteen patients with end-stage hepatocirrhosis,child-pugh grade C,underwent orthotopic liver transplantation.All of them had coagulation disorder in various degrees.Six of them with preoperative international normalized ratio(INR)>3.0 received artificial liver therapy.Blood preparations were used to modulate coagulation function during operation.Body temperature and serum concentration of Ca2+ were also carefully regulated.Blood samples were collected for the measurements of coagulation,biochemical indexes,blood routine test and thromboelastogram at the time points of preoperative phase(T0),anhepatic phase(5 min after inferior vena cava occlusion,T1),neohepatic phase(5 min after inferior vena cava patefaction,T2) and wound closure phase(T3).Results Compared with T0,the albumin concentration at T1,T2,T3 was significantly decreased(P<0.05 or P<0.01),but no statistical differences were found among the other indexes.Conclusion Fresh frozen plasma and platelet should be primarily used to modulate coagulation function during liver transplantation.Cryoprecipitate and fibrinogen are useful if necessary.Coagulation function should be mornitored carefully to maintain it at an appropriate lower level in order to avoid thrombosis after operation.
What problem does this paper attempt to address?